Bipolar Depression Relapse Study: Prevention of Relapse and Recurrence of Bipolar Depression

Comparing 2 Doses of LuAA21004 in Acute Treatment of Adults with Major Depressive Disorder: A Phase 3, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Fixed-Dose Study Comparing the Efficacy and Safety of 2 Doses (10 and 20 mg) of Lu-AA21004 in Acute Treatment of Adults with Major Depressive Disorder

Depression (Treatment Study): Rush Depression Trials

Efficacy and Safety of Agomelatine in Patients With Major Depressive Disorder: An 8-week, randomized, double-blind, placebo-controlled, parallel-group, multicenter study of the efficacy and safety of agomelatine 0.5 mg and 1 mg sublingual tablets administered once daily in patients with major depressive disorder (MDD)

Major Depressive Disorder Study: A Study of the efficacy of augmenting selective serotonin reuptake inhibitor (SSRI) medication in patients with major depressive disorder (MDD) resistant to treatment with SSRIs.

Metabolic Complications Associated with Olanzapine: Metformin to prevent Metabolic Complications associated with Olanzapine

Panic Disorder Treatment Study: Cognitive Behavioral Therapy and Medication in the Treatment of Panic Disorder

Schizophrenia Long Acting Injectable Treatment Study: A 38 week, double-blind study of a long-acting injectable, second generation antipsychotic medication compared to its oral formulation as a maintenance treatment for schizophrenia

Schizophrenia Research Study: Schizophrenia Research Study

Sleep Disturbance in PTSD Study: Treating Sleep Disturbance in Post-Traumatic Stress Disorder (PTSD)

Spanish-Speaking Older Adult Trauma Survivor Stress Reduction Study: UNIDOS, Stress Reduction for Spanish-Speaking Older Adult Trauma Survivors